AACR Annual Meeting 2017: Challenging the Dogma of Treating IDH-mutant Cancers With IDH Inhibitors
Two studies presented at the AACR Annual Meeting 2017 showed that tumors that have mutations in the proteins isocitrate...
Category: Research
Two studies presented at the AACR Annual Meeting 2017 showed that tumors that have mutations in the proteins isocitrate...
The U.S. Food and Drug Administration (FDA) has approved expanding the use of the immunotherapeutic pembrolizumab (Keytruda) to include...
The AACR has a robust program of educational workshops designed to equip early-career investigators with the knowledge, skills, and...
The AACR Annual Meeting, to be held in Washington, D.C., April 1-5, will showcase the best cancer science and...
As the American population grows ever more diverse, cancer researchers are discovering that digging deep into demographic information can...
The fact that there are differences in screening mammography recommendations highlights the need for additional research into the benefits...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved expanding the use of the...
Saturday, February 4, is World Cancer Day, an initiative of the Union for International Cancer Control (UICC).
Patients have long benefited from combination treatments—whether combining surgery with chemotherapy and radiation, or combining chemotherapy agents in succession.
A hot topic in the field of cancer immunotherapy is: How do some cancers that initially respond to immune...